Join us for our next webinar on Wednesday 7th May 2025, where our 2 panelists, Dr Rodrigues & Dr Katz, will discuss the real impact of in vitro kidney models in producing higher quality data and ultimately safer drugs.
Utilization of high – content imaging for the study of lung fibrosis
High content imaging (HCI) assays enable the study of the fibrotic processes: fibroblast – to – myofibroblast transition (FMT) and epithelial – to – mesenchymal transition (EMT)
The aProximateTM model for renal drug safety/efficacy and transporter studies
Development of photoreceptor outer segments in human iPSC derived retinal organoids produced at large scale
Developing predictive in vitro Glomerulus , Proximal Tubule and Loop of Henle renal cell model platforms to investigate the renal uptake and nephrotoxic liability of large molecules
An in vitro model that predicts Antibiotic Renal Toxicity
Modelling Epithelial Barrier Function and Mucociliary Clearance Using Small Airway Epithelium Cells
A high-throughput, in vitro assessment of antibiotic induced podocyte injury
A Primary Human in vitro Focal Segmental Glomerulosclerosis (FSGS) model for drug development applications